63.3
[1]. Alexandre-Gouabau MC, et al. Comprehensive Preterm Breast Milk Metabotype Associated with Optimal Infant Early GrowthPattern. Nutrients. 019 Feb 8;11(3).
[]. Aaron D Mills, et al. Design and synthesis of a hybrid potentiator-corrector agonist of the cystic fibrosis mutant protein DeltaF508-CFTR. Bioorg Med Chem Lett. 010 Jan 1;0(1):87-91.
[3]. Antonella Caputo, et al. Mutation-specific potency and efficacy of cystic fibrosis transmembrane conductance regulator chloride channel potentiators. J Pharmacol Exp Ther. 009 Sep;330(3):783-91.
[4]. Choedchai Saehuan, et al. Isolation and characterization of a benzoylformate decarboxylase and a NAD+/NADP+-dependent benzaldehyde dehydrogenase involved in D-phenylglycine metabolism in Pseudomonas stutzeri ST-01. Biochim Biophys Acta. 007 Nov;1770(11):1585-9.
[5]. David A Ostrov, et al. Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening. Antimicrob Agents Chemother. 007 Oct;51(10):3688-98.
H30-H315-H319-H335
P61-P64-P70-P71-P80-P30+P35-P304+P340-P305+P351+P338-P330-P36+P364-P403+P33-P405-P501
![]()